Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Glioblastoma 4Pancreatic Neoplasms 3Multiple Myeloma 3Neoplasms 2Glioma 2Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Oligodendroglioma 1Obesity 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Gliosarcoma 1Colorectal Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Metformin 2rosiglitazone-metformin combination 1mirabegron 1exemestane 1atezolizumab 1Tirzepatide 1TIC10 compound 1Rosiglitazone 1Hydroquinones 1Fish Oils 1Docosahexaenoic Acids 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Obesity × Ascorbic Acid × Clear all
NCT03049462 2026-06-01

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
100 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡